RB1 and cancer: Regarding cis-regulatory sequences, the systematic analysis of multiple cancer types revealed that somatic mutations do not only disrupt canonical splice sites, but can also lead to de novo splice sites in cancer-related genes such as TP53, ATRX, BAP1 CTNNB1, RB1, and more [131].